Launch Invitation: Independent Evaluation of the I-ENAACT Program 2011

Launch Invitation: Independent Evaluation of the I-ENAACT Program 2011 - 2014

Launch Invitation: Independent Evaluation of the 'Implementing Expanded

Naloxone Availability in the ACT (I-ENAACT) Program' 2001 -2014

To mark Overdose Awareness Day on 31 August 2015, there will be a launch of the Independent Evaluation of the ‘Implementing Expanded Naloxone Availability in the ACT (I-ENAACT) Program’ 2011 - 2014.

The Canberra Alliance for Harm Minimisation and Advocacy (CAHMA), ACT Health, ATODA and a multi-disciplinary group of stakeholders initiated Australia’s first takehome naloxone program in 2011. Naloxone is an opioid antagonist used to reverse the effects of opioid overdose. The ACT program involves comprehensive opioid overdose management training and the prescription and supply of take-home naloxone to eligible participants who are not health professionals. Using a collaborative approach the program is coordinated and delivered by CAHMA, with prescriptions provided by local general practitioners in the community and in prison and supplied by local pharmacists.

The program’s evaluation findings will be presented, including opportunities for the ACT to continue to take a leading role in promoting the health of people who use drugs and their families and friends; and preventing and reducing death, disability and injury from opioid overdoses.

Speakers include:

Mr Simon Corbell, Minister for Health
Mr Sione Crawford, Canberra Alliance for Harm Minimisation and Advocacy
Professor Simon Lenton, National Drug Research Institute, Curtin University
Dr Anna Olsen, The Australian National University
Mr David McDonald, Social Research and Evaluation
Mrs Agnes Shea OAM, Ngunnawal Elder
Ms Carrie Fowlie, Alcohol Tobacco and Other Drug Association ACT (ATODA)

Date: Monday 31 August 2015
Time: 10am – 11:30am. (Arrivals from 9:45am. Formalities will end before 11am and will be followed by morning tea)
Venue: Reception Room, Legislative Assembly of the ACT, 196 London Circuit, Canberra City
RSVP: All welcome. Please RSVP for catering purposes to info@atoda.org.au or (02) 6255 4070 by 27 August 2015.

For more information: Download the flyer, visit the ATODA website or read more about Expanding Naloxone Availability in the ACT.


Contact ATODA: Phone: (02) 6255 4070 Fax: (02) 6255 4649 Email: info@atoda.org.au Mail: PO Box 7187, Watson ACT 2602 Visit: 350 Antill St. Watson Access Previous E-Bulletins
Unsubscribe from the eBulletin \| Update preferences The Alcohol Tobacco and Other Drug Association ACT (ATODA) is the peak body representing the non-government and government alcohol, tobacco and other drug (ATOD) sector in the Australian Capital Territory (ACT). ATODA seeks to promote health through the prevention and reduction of the harms associated with ATOD. Views expressed in the ACT ATOD Sector eBulletin do not necessarily reflect the opinion of the Alcohol Tobacco and Other Drug Association ACT. Not all third-party events or information included in the eBulletin are endorsed by the ACT ATOD Sector or the Alcohol Tobacco and Other Drug Association ACT. No responsibility is accepted by the Alcohol Tobacco and Other Drug Association ACT or the editor for the accuracy of information contained in the eBulletin or the consequences of any person relying upon such information. To contact us please email ebulletin@atoda.org.au or call (02) 6255 4070.